Is the decision for colorectal resection justified by histopathologic findings:: a prospective study of 100 patients with advanced ovarian cancer

被引:41
作者
Hertel, H
Diebolder, H
Herrmann, J
Köhler, C
Kühne-Heid, R
Possover, M
Schneider, A
机构
[1] Univ Jena, Dept Gynecol, D-07740 Jena, Germany
[2] Univ Jena, Inst Pathol, D-07740 Jena, Germany
关键词
advanced ovarian cancer; colorectal resection; histopathologic findings;
D O I
10.1006/gyno.2001.6338
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. We compare the indication for colorectal resection in patients with advanced ovarian cancer with histopathologic findings. We describe the effect on pelvic control and morbidity associated with surgery. Methods. Between February 1995 and March 2001, 100 patients with FIGO stage III ovarian cancer underwent pelvic en bloc resection with excision of the rectosigmoid colon as part of primary or secondary cytoreductive surgery. Decision for resection was made by the surgeon when tumor involvement of the cul-de-sac was suspected. Rectosigmoid infiltration was histopathologically defined as infiltration of the serosa or deeper. Results. In 73 of 100 patients (73%) tumor involvement of the rectum was confirmed histopathologically: infiltration of the serosa in 28 (28%) patients, infiltration of the muscularis in 31 (31, patients, and infiltration of the mucosa in 14 (14%) patients; in 27 (27%) patients no infiltration was found. Histopathologically confirmed pelvic RO resection was achieved in 85 (85 %) patients. In 11 (11%) patients the pelvic resection margins were tumor-involved and in four (4%) patients visible parametric tumor remained in situ. Pelvic recurrence occurred in 4 (4.7%) of 85 optimally de-bulked patients compared with 9 (60%) of 15 patients with suboptimal pelvic resection status (P < 0.05). End colostomy could be prevented in 94 (94%) of 100 patients. Conclusion. Pelvic en bloc surgery with rectosigmoid resection was justified by histopathologic outcome since deperitonealization with preservation the rectosigmoid would have left tumor in situ in 73% of patients with suspected cul-de-sac involvement. (C) 2001 Academic Press
引用
收藏
页码:481 / 484
页数:4
相关论文
共 19 条
[1]   The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma [J].
BenedettiPanici, P ;
Maneschi, F ;
Scambia, G ;
Cutillo, G ;
Greggi, S ;
Mancuso, S .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (04) :532-538
[2]  
EISENKOP SM, 1995, CANCER, V76, P1606, DOI 10.1002/1097-0142(19951101)76:9<1606::AID-CNCR2820760917>3.0.CO
[3]  
2-H
[4]   Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study [J].
Eisenkop, SM ;
Friedman, RL ;
Wang, HJ .
GYNECOLOGIC ONCOLOGY, 1998, 69 (02) :103-108
[5]  
EISENKOP SM, 1991, OBSTET GYNECOL, V78, P879
[6]  
GERSHENSON DM, 1994, OBSTET GYN CLIN N AM, V21, P121
[7]   EXTENSIVE PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED EPITHELIAL OVARIAN-CANCER [J].
GUIDOZZI, F ;
BALL, JHS .
GYNECOLOGIC ONCOLOGY, 1994, 53 (03) :326-330
[8]  
HACKER NF, 1983, OBSTET GYNECOL, V61, P413
[9]  
HUDSON C N, 1973, Gynecologic Oncology, V1, P370, DOI 10.1016/0090-8258(73)90029-2
[10]  
HUDSON CN, 1968, J OBSTET GYN BR COMM, V75, P1161